The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Antimicrobial peptides: A novel and promising arsenal against methicillin-resistant Staphylococcus aureus (MRSA) infections
Abstract
Antimicrobial peptides (AMPs), with their precise targeting mechanisms and innate modifiability, have emerged as promising therapeutic agents. By selectively interrupting bacterial processes and boosting innate immunological responses, AMPs offer a multifaceted strategy. Modern biotechnological and bioinformatics advancements have enabled the refinement of AMPs for improved efficacy. This comprehensive review delves into the intricate facets of MRSA pathogenicity, determinants of resistance, foundational tenets of peptide-based therapeutics, and recent scientific breakthroughs. A comprehensive analysis of the current research landscape, clinical implications, and persistent challenges underscores the potential of precisely tailored peptides as formidable weapons for counteracting the enduring threat of MRSA infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some strains produce staphylokinase, an enzyme that degrades antimicrobial peptides, reducing host immune clearance [21,22].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
Kluytmans, J., van Belkum, A., & Verbrugh, H. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.3.505 · Cited by 2,595
Bacteriocins: Developing innate immunity for food
Cotter, P. D., Hill, C., & Ross, R. P. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1273 · Cited by 2,380 · cited 1×
“This limitation was overcome by the invention of Genetic Code Expansion approximately 20 years ago [114,115].”
Nasal Carriage as a Source of Staphylococcus aureus Bacteremia
von Eiff, C., Becker, K., Machka, K., Stammer, H., & Peters, G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440102 · Cited by 1,984
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
An Expanded Eukaryotic Genetic Code
Chin, J. W., Cropp, T. A., Anderson, J. C., Mukherji, M., Zhang, Z., & Schultz, P. G. (2003) · Science · doi:10.1126/science.1084772 · Cited by 820 · cited 1×
“Consequently, a priceless collection of tools has become available to study and work with proteins [122 – 127].”
Strategic Approaches to Optimizing Peptide ADME Properties
Di, L. (2015) · The AAPS Journal · doi:10.1208/s12248-014-9687-3 · Cited by 669 · cited 1×
“Heterodetic cyclization plays a crucial role in controlling the overall shape and characteristics of cyclic peptides by carefully placing disul fi de links [105,106].”
Mechanisms of vancomycin resistance in Staphylococcus aureus
Gardete, S., & Tomasz, A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68834 · Cited by 565
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
Proschak, E., Stark, H., & Merk, D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00760 · Cited by 498
Essential Oils, A New Horizon in Combating Bacterial Antibiotic Resistance
Yap, P. S. X., Yiap, B. C., Ping, H. C., & Lim, S. H. E. (2014) · The Open Microbiology Journal · doi:10.2174/1874285801408010006 · Cited by 426 · cited 1×
“In contrast, AMPs adopt a more comprehensive strategy by destabilizing bacterial membranes, impeding internal processes, and even adjusting the host immune response to effectively combat infections [32].”
An anti-infective peptide that selectively modulates the innate immune response
Scott, M. G., Dullaghan, E., Mookherjee, N., Glavas, N., Waldbrook, M., Thompson, A., Wang, A., Lee, K., Doria, S., Hamill, P., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1288 · Cited by 403
Research works printed but not linked: 150
- Lowy, 1998, Staphylococcus aureus infections, N. Engl. J. Med., 339, 520, 10.1056/NEJM199808203390806 · DOI · Paper page
- F.A. Waldvogel, Staphylococcus aureus. In: G.L. Mandell, R.G. Douglas & J.E. Bennett (ed.), Principles and Practices of Infectious Disease, third ed. Churchill Livingstone, Philadelphia, Pennsylvania, USA, 121(8) 1754-1777..
- De Oliveira, 2020, Antimicrobial resistance in ESKAPE pathogens, Clin. Microbiol. Rev., 33, 10.1128/CMR.00181-19 · DOI · Paper page
- Murray, 2022, Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis, Lancet, 399, 629, 10.1016/S0140-6736(21)02724-0 · DOI · Paper page
- Hryniewicz, Epidemiology of MRSA, Infection 27 (Suppl 2) (1999) S13–S16, https://doi.org/10.1007/BF02561663. · DOI · Paper page
- Mlynarczyk, 2009, Mechanisms of the resistance and tolerance to beta-lactam and glycopeptide antibiotics in pathogenic gram-positive cocci, Mini Rev. Med. Chem., 9, 1527, 10.2174/138955709790361557 · DOI · Paper page
- Huang, 2010, Alpha-helical cationic antimicrobial peptides: relationships of structure and function, Protein Cell, 1, 143, 10.1007/s13238-010-0004-3 · DOI · Paper page
- Lei, 2019, The antimicrobial peptides and their potential clinical applications, Am. J. Transl. Res., 11, 3919
- Mallapragada, 2017, Antimicrobial peptides: the miraculous biological molecules, J. Indian Soc. Periodontol., 21, 434, 10.4103/jisp.jisp_325_16 · doi:10.4103/jisp.jisp_325_16
- Florin, 2017, An antimicrobial peptide that inhibits translation by trapping release factors on the ribosome, Nat. Struct. Mol. Biol., 24, 752, 10.1038/nsmb.3439 · DOI · Paper page
- Xuan, 2023, Antimicrobial peptides for combating drug-resistant bacterial infections, Drug Resist. Updates, 68, 100954, 10.1016/j.drup.2023.100954 · DOI · Paper page
- Lei, 2019, The antimicrobial peptides and their potential clinical applications, Am. J. Transl. Res., 11, 3919
- Jenssen, 2006, Peptide antimicrobial agents, Clin. Microbiol. Rev., 19, 491, 10.1128/CMR.00056-05 · DOI · Paper page
- Zhang, 2016, Antimicrobial peptides, Curr. Biol., 26, 14, 10.1016/j.cub.2015.11.017 · DOI · Paper page
- Pasupuleti, 2012, Antimicrobial peptides: key components of the innate immune system, Crit. Rev. Biotechnol., 32, 143, 10.3109/07388551.2011.594423 · DOI · Paper page
- Haney, 2017, Antimicrobial peptides: an introduction, Methods Mol. Biol., 1548, 3, 10.1007/978-1-4939-6737-7_1 · DOI · Paper page
- Boparai, 2020, Mini review on antimicrobial peptide, sources, mechanism and recent applications, Protein Pept. Lett., 27, 4, 10.2174/18755305MTAwENDE80 · DOI · Paper page
- Dennison, 2018, An atlas of anionic antimicrobial peptides from amphibians, Curr. Protein Pept. Sci., 19, 823, 10.2174/1389203719666180226155035 · DOI
- Teixeira, 2012, Role of lipids in the interaction of antimicrobial peptides with membranes, Prog. Lipid Res., 51, 149, 10.1016/j.plipres.2011.12.005 · DOI · Paper page
- Gennaro, 2000, Structural features and biological activities of the cathelicidin-derived antimicrobial peptides, Biopolymers, 55, 31, 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.0.CO;2-9 · DOI · Paper page
- Harris, 2009, Anionic antimicrobial peptides from eukaryotic organisms, Curr. Protein Pept. Sci., 10, 585, 10.2174/138920309789630589 · DOI · Paper page
- Lakshmaiah Narayana, 2015, Antimicrobial peptides: possible anti-infective agents, Peptides, 72, 88, 10.1016/j.peptides.2015.05.012 · DOI · Paper page
- Jeżowska-Bojczuk, 2018, Peptides having antimicrobial activity and their complexes with transition metal ions, Eur. J. Med. Chem., 143, 997, 10.1016/j.ejmech.2017.11.086 · DOI
- Tasiemski, 2004, Molecular characterization of two novel antibacterial peptides inducible upon bacterial challenge in an annelid, the leech Theromyzon tessulatum, J. Biol. Chem., 279, 30973, 10.1074/jbc.M312156200 · DOI
- Jiang, 2014, Preparation and identification of peptides and their zinc complexes with antimicrobial activities from silver carp (Hypophthalmichthys molitrix) protein hydrolysates, Food Res. Int., 64, 91, 10.1016/j.foodres.2014.06.008 · DOI
- Rathinakumar, 2010, High-throughput discovery of broad-spectrum peptide antibiotics, Faseb. J., 24, 3232, 10.1096/fj.10-157040 · DOI
- Bahar, 2013, Antimicrobial peptides, Pharmaceuticals, 6, 1543, 10.3390/ph6121543 · DOI · Paper page
- Chen, 2007, Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides, Antimicrob, Agents Chemother, 51, 1398, 10.1128/AAC.00925-06 · DOI · Paper page
- Som, 2008, Synthetic mimics of antimicrobial peptides, Peptide Sci, 90, 83, 10.1002/bip.20970 · DOI
- Passioura, 2014, Selection-based discovery of druglike macrocyclic peptides, Annu. Rev. Biochem., 83, 727, 10.1146/annurev-biochem-060713-035456 · DOI · Paper page
- Vagner, 2008, Peptidomimetics, a synthetic tool of drug discovery, Curr. Opin. Chem. Biol., 12, 292, 10.1016/j.cbpa.2008.03.009 · DOI · Paper page
- N. Malanovic, L. Marx, S.E. Blondelle, G. Pabst, E.F. Semeraro, Experimental concepts for linking the biological activities of antimicrobial peptides to their molecular modes of action, Biochim. Biophys. Acta, Biomembr. 1862 · DOI
- (8) (2020) 183275, https://doi.org/10.1016/j.bbamem.2020.183275. · DOI
- R. Santos, D. Ruza, E. Cunha, L. Tavares, M. Oliveira, Diabetic foot infections: application of a nisin-biogel to complement the activity of conventional antibiotics and antiseptics against Staphylococcus aureus biofilms, PLoS One 14 (7) (2019) e0220000, https://doi.org/10.1371/journal.pone.0220000. · DOI
- Williamson, 2017, Current and emerging topical antibacterials and antiseptics: agents, action, and resistance patterns, Clin. Microbiol. Rev., 30, 827, 10.1128/CMR.00112-16 · DOI · Paper page
- Fjell, 2012, Designing antimicrobial peptides: form follows function, Nat. Rev. Drug Discov., 11, 37, 10.1038/nrd3591 · DOI · Paper page
- Shurko, 2018, Evaluation of LL-37 antimicrobial peptide derivatives alone and in combination with vancomycin against S. aureus, J. Antibiot., 71, 971, 10.1038/s41429-018-0090-7 · DOI
- Thapa, 2020, Topical antimicrobial peptide formulations for wound healing: current developments and future prospects, Acta Biomater, 103, 52, 10.1016/j.actbio.2019.12.025 · DOI · Paper page
- Hakur, 2022, In pursuit of next-generation therapeutics: antimicrobial peptides against superbugs, their sources, mechanism of action, nanotechnology-based delivery, and clinical applications, Int. J. Biol. Macromol., 218
- K.E. Ridyard, J. Overhage, The potential of human peptide LL-37 as an antimicrobial and anti-biofilm agent, Antibiotics 10 (6) (2021) 650, https://doi.org/10.3390/antibiotics10060650. · DOI · Paper page
- Sim, 2013, Multiple site surveillance cultures as a predictor of methicillin-resistant Staphylococcus aureus infections, Infect. Control Hosp. Epidemiol., 34, 818, 10.1086/671273 · DOI
- D.J. Diekema, M.A. Pfaller, F.J. Schmitz, J. Smayevsky, J. Bell, R.N. Jones, M. Beach, Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999, Clin. Infect. Dis. 32 (Suppl. 2) (2001) S114–S132, https://doi.org/10.1086/320184. · DOI · Paper page
- Enright, 2000, Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus, J. Clin. Microbiol., 38, 1008, 10.1128/JCM.38.3.1008-1015.2000 · DOI · Paper page
- M. Emonts, et al., Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils, J. Infect. Dis. 197 (9) (2008) 1244–1253, https://doi.org/10.1086/533501. · DOI
- C. Weidenmaie, J.F. Kokai-Kun, E. Kulauzovic, T. Kohler, G. Thumm, H. Stoll, F. Göt, A. Peschel, Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization, Int. J. Med. Microbiol. 298 (5–6) (2008) 505–513, https://doi.org/10.1016/j.ijmm.2007.11.006. · DOI
- H.F. Wertheim, E. Walsh, R. Choudhurry, D.C. Melles, H.A.M. Boelens, H. Miajlovic, H.A. Verbrugh, T. Foster, A. van Belkum, Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans, PLoS Med. 5 (1) (2008) e17, https://doi.org/10.1371/journal.pmed.0050017. · DOI · Paper page
- O’Brien, 2002, Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization, Cell Microbiol, 4, 759, 10.1046/j.1462-5822.2002.00231.x · DOI · Paper page
- S. Boyle-Vavra, X. Li, T. Alam, T.D. Read, J. Sieth, C. Cywes-Bentley, G. Dobbins, USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locus, mBio 6 (2) (2015) e02585-14, https://doi.org/10.1128/mbio.02585-14. · DOI
- Spaan, 2017, Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors, Nat. Rev. Microbiol., 15, 435, 10.1038/nrmicro.2017.27 · DOI · Paper page
- Kluytmans, 1995, Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery, J. Infect. Dis., 171, 216, 10.1093/infdis/171.1.216 · DOI · Paper page
- Foster, 2014, Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus, Nat. Rev. Microbiol., 12, 49, 10.1038/nrmicro3161 · DOI · Paper page
- Cheng, 2011, A play in four acts: Staphylococcus aureus abscess formation, Trends Microbiol, 19, 225, 10.1016/j.tim.2011.01.007 · DOI · Paper page
- Laarman, 2010, Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications, J. Mol. Med., 88, 115, 10.1007/s00109-009-0572-y · DOI
- K.Y. Le, M. Otto, Quorum-sensing regulation in staphylococci-an overview, Front. Microbiol. 6 (2015) 1174, https://doi.org/10.3389/fmicb.2015.01174. · DOI · Paper page
- Cheung, 2011, Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis, Infect. Immun., 79, 1927, 10.1128/IAI.00046-11 · DOI · Paper page
- Crisostomo, 2001, The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones, Proc. Natl. Acad. Sci. U.S.A., 98, 9865, 10.1073/pnas.161272898 · DOI · Paper page
- 2009, on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC), Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements, Antimicrob. Agents Chemother., 53, 4961, 10.1128/AAC.00579-09 · DOI · Paper page
- Bal, 2016, Genomic insights into the emergence and spread of international clones of healthcare-, community- and livestock-associated meticillin-resistant Staphylococcus aureus: blurring of the traditional definitions, J. Glob. Antimicrob. Resist, 6, 95, 10.1016/j.jgar.2016.04.004 · DOI
- Hartman, 1984, Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus, J. Bacteriol., 158, 513, 10.1128/jb.158.2.513-516.1984 · DOI · Paper page
- L. Garcia-Alvarez, et al., Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study, Lancet Infect. Dis. 11 (8) (2011) 595–603, https://doi.org/10.1016/S1473-3099(11)70126-8. · DOI · Paper page
- Becker, 2018, Plasmid-encoded transferable mecB-mediated methicillin resistance in Staphylococcus aureus, Emerg. Infect. Dis., 24, 242, 10.3201/eid2402.171074 · DOI · Paper page
- Hancock, 2006, Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies, Nat. Biotechnol., 24, 1551, 10.1038/nbt1267 · DOI · Paper page
- Peschel, 2006, The co-evolution of host cationic antimicrobial peptides and microbial resistance, Nat. Rev. Microbiol., 4, 529, 10.1038/nrmicro1441 · DOI · Paper page
- Nguyen, 2011, The expanding scope of antimicrobial peptide structures and their modes of action, Trends Biotechnol, 29, 464, 10.1016/j.tibtech.2011.05.001 · DOI · Paper page
- Jenssen, 2006, Peptide antimicrobial agents, Clin. Microbiol. Rev., 19, 491, 10.1128/CMR.00056-05 · DOI · Paper page
- Endo, 1997, Fungicidal action of aureobasidin A, a cyclic depsipeptide antifungal antibiotic, against Saccharomyces cerevisiae, Antimicrob. Agents Chemother., 41, 672, 10.1128/AAC.41.3.672 · DOI
- Hale, 2007, Alternative mechanisms of action of cationic antimicrobial peptides on bacteria, Expert Rev. Anti InfectTher., 5, 951, 10.1586/14787210.5.6.951 · DOI · Paper page
- Czub, 2006, Comparative molecular dynamics study of lipid membranes containing cholesterol and ergosterol, Biophys. J., 90, 2368, 10.1529/biophysj.105.072801 · DOI · Paper page
- Levitz, 1986, In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages, J. Infect. Dis., 154, 483, 10.1093/infdis/154.3.483 · DOI · Paper page
- van der Weerden, 2010, Permeabilization of fungal hyphae by the plant defensinNaD1 occurs through a cell wall-dependent process, J. Biol. Chem., 285, 37513, 10.1074/jbc.M110.134882 · DOI · Paper page
- Cavassin, 2021, Sixty years of amphotericin B : an overview of the main antifungal agent used to treat invasive fungal infections, Infect. Dis. Ther., 10, 115, 10.1007/s40121-020-00382-7 · DOI · Paper page
- De Cesare, 2020, Antimicrobial peptides: a new frontier in antifungal therapy, mBio, 11, 1
- Yasir, 2018, Action of antimicrobial peptides against bacterial biofilms, Materials, 11, 2468, 10.3390/ma11122468 · DOI · Paper page
- Martinez, 2019, Synergistic and antibiofilm activity of the antimicrobial peptide P5 against carbapenem-resistant Pseudomonas aeruginosa, Biochim. Biophys. Acta Biomembr., 1861, 1329, 10.1016/j.bbamem.2019.05.008 · DOI
- Goldberg, 2013, Sensitization of gram-negative bacteria by targeting the membrane potential, Faseb. J., 27, 3818, 10.1096/fj.13-227942 · DOI
- Marks, 2012, The human milk protein-lipid complex HAMLET sensitizes bacterial pathogens to traditional antimicrobial agents, PLoS One, 7, 10.1371/journal.pone.0043514 · DOI
- Nicolas, 2009, Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides, FEBS J, 276, 6483, 10.1111/j.1742-4658.2009.07359.x · DOI · Paper page
- Schneider, 2010, Plectasin, a fungal defensin, targets the bacterial cell wall precursor lipid II, Science, 328, 1168, 10.1126/science.1185723 · DOI · Paper page
- Hasper, 2006, An alternative bactericidal mechanism of action for antibiotic peptides that target lipid II, Science, 313, 1636, 10.1126/science.1129818 · DOI · Paper page
- Boman, 1993, Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine, Infect. Immun., 61, 2978, 10.1128/iai.61.7.2978-2984.1993 · DOI · Paper page
- Patrzykat, 2002, Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli, Antimicrob, Agents Chemother, 46, 605, 10.1128/AAC.46.3.605-614.2002 · DOI · Paper page
- Subbalakshmi, 1998, Mechanism of antimicrobial action of indolicidin, FEMS Microbiol. Lett., 160, 91, 10.1111/j.1574-6968.1998.tb12896.x · doi:10.1111/j.1574-6968.1998.tb12896.x · Paper page
- Nan, 2009, Investigating the effect of positive charge and hydrophobicity on the cell selectivity, mechanism of action and anti- inflammatory activity of a Trp-rich antimicrobial peptide indolicidin, FEMS Microbiol. Lett., 292, 134, 10.1111/j.1574-6968.2008.01484.x · DOI
- Yang, 2001, Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37), J. Leukoc. Biol., 69, 691, 10.1189/jlb.69.5.691 · DOI · Paper page
- Niyonsaba, 2002, A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis, Immunol, 106, 20, 10.1046/j.1365-2567.2002.01398.x · DOI · Paper page
- Tjabringa, 2006, Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors, Int. Arch. Allergy Immunol., 140, 103, 10.1159/000092305 · DOI · Paper page
- Mookherjee, 2009, Intracellular receptor for human host defense peptide LL-37 in monocytes, J. Immunol., 183, 2688, 10.4049/jimmunol.0802586 · DOI · Paper page
- Montreekachon, 2011, Involvement of P2X (7) purinergic receptor and MEK1/2 in interleukin-8 up-regulation by LL-37 in human gingival fibroblasts, J. Periodontal. Res., 46, 327, 10.1111/j.1600-0765.2011.01346.x · DOI
- Cavaillon, 2003, Cytokine cascade in sepsis, Scand. J. Infect. Dis., 35, 535, 10.1080/00365540310015935 · DOI · Paper page
- Zisman, 1997, MCP-1 protects mice in lethal endotoxemia, J. Clin. Investig., 99, 2832, 10.1172/JCI119475 · DOI · Paper page
- Bommineni, 2010, A fowlicidin-1 analog protects mice from lethal infections induced by methicillin-resistant Staphylococcus aureus, Peptides, 31, 1225, 10.1016/j.peptides.2010.03.037 · DOI
- van der Does, 2010, Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor- driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens, Antimicrob. Agents Ch., 54, 811, 10.1128/AAC.00652-09 · DOI
- Luo, 2021, Mechanism of antimicrobial peptides: antimicrobial, antiinflammatory and antibiofilm activities, Int. J. Mol. Sci., 22, 11401, 10.3390/ijms222111401 · DOI · Paper page
- Mataraci, 2012, In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms, Antimicrob. Agents Chemother., 56, 6366, 10.1128/AAC.01180-12 · DOI
- Waters, 2005, Quorum sensing: cell-to-cell communication in bacteria, Annu. Rev. Cell Dev. Biol., 21, 319, 10.1146/annurev.cellbio.21.012704.131001 · DOI · Paper page
- Orlando, 2008, BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection, Peptides, 29, 1118, 10.1016/j.peptides.2008.03.005 · DOI
- Balaban, 2004, A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci, Antimicrob, Agents Chemother, 48, 2544, 10.1128/AAC.48.7.2544-2550.2004 · DOI
- Ganz, 2003, Defensins: antimicrobial peptides of innate immunity, Nat. Rev. Immunol., 3, 710, 10.1038/nri1180 · DOI · Paper page
- Scudiero, 2015, Design and activity of a cyclic mini-beta-defensin analog: a novel antimicrobial tool, Int. J. Nanomed., 10, 6523
- Dathe, 2004, Cyclization increases the antimicrobial activity and selectivity of arginine- and tryptophan-containing hexapeptides, Biochemistry, 43, 9140, 10.1021/bi035948v · DOI · Paper page
- Costa, 2019, Clinical application of AMPs, Adv. Exp. Med. Biol., 1117, 281, 10.1007/978-981-13-3588-4_15 · DOI
- Usmani, 2017, THPdb: Database of FDA-approved peptide and protein therapeutics, PLoS One, 12, 10.1371/journal.pone.0181748 · DOI · Paper page
- Cheneval, 2014, Fmoc-based synthesis of disulfide-rich cyclic peptides, J. Org. Chem., 79, 5538, 10.1021/jo500699m · DOI
- Falanga, 2017, Cyclic peptides as novel therapeutic microbicides: engineering of human defensin mimetics, Molecules, 22, 10.3390/molecules22071217 · DOI
- Monaim, 2018, Teixobactin as a scaffold for unlimited new antimicrobial peptides: SAR study, Bioorg. Med. Chem., 26, 2788, 10.1016/j.bmc.2017.09.040 · DOI
- Peschel, 2006, The co-evolution of host cationic antimicrobial peptides and microbial resistance, Nat. Rev. Microbiol., 4, 529, 10.1038/nrmicro1441 · DOI · Paper page
- Wang, 2001, Expanding the genetic code of Escherichia coli, Science, 292, 498, 10.1126/science.1060077 · DOI · Paper page
- Wang, 2004, Expanding the genetic code, Angew. Chem., Int. Ed. Engl., 44, 34, 10.1002/anie.200460627 · DOI · Paper page
- Oller-Salvia, 2019, Efficient phage display with multiple distinct noncanonical amino acids using orthogonal ribosome-mediated genetic code expansion, Angew. Chem., Int. Ed. Engl., 131, 10960, 10.1002/ange.201902658 · DOI
- Wang, 2017, Engineering the genetic code in cells and animals: biological considerations and impacts, Acc. Chem. Res., 50, 2767, 10.1021/acs.accounts.7b00376 · DOI
- Wang, 2001, Expanding the genetic code of Escherichia coli, Science, 292, 498, 10.1126/science.1060077 · DOI · Paper page
- Santoro, 2002, An efficient system for the evolution of aminoacyl-tRNA synthetase specificity, Nat. Biotechnol., 20, 1044, 10.1038/nbt742 · DOI · Paper page
- Anderson, 2004, An expanded genetic code with a functional quadruplet codon, Proc. Natl. Acad. Sci. U.S.A., 101, 7566, 10.1073/pnas.0401517101 · DOI · Paper page
- Niu, 2013, An expanded genetic code in mammalian cells with a functional quadruplet codon, ACS Chem. Biol., 8, 1640, 10.1021/cb4001662 · DOI
- Valentini, 2020, Bioorthogonal non-canonical amino acid tagging reveals translationally active subpopulations of the cystic fibrosis lung microbiota, Nat. Commun., 11, 2287, 10.1038/s41467-020-16163-2 · DOI
- Ernst, 2016, Genetic code expansion in the mouse brain, Nat. Chem. Biol., 12, 776, 10.1038/nchembio.2160 · DOI
- Liu, 2017, Genetic code expansion in zebrafish embryos and its application to optical control of cell signalling, J. Am. Chem. Soc., 139, 9100, 10.1021/jacs.7b02145 · DOI
- Brown, 2018, Genetic code expansion in animals, ACS Chem. Biol., 13, 2375, 10.1021/acschembio.8b00520 · DOI
- Wang, 2014, Construction of a live-attenuated HIV-1 vaccine through genetic code expansion, Angew. Chem., 126, 4967, 10.1002/ange.201402092 · DOI
- Si, 2016, Generation of influenza A viruses as live but replication-incompetent virus vaccines, Science, 354, 1170, 10.1126/science.aah5869 · DOI · Paper page
- Y. Zheng, et al., Broadening the versatility of lentiviral vectors as a tool in nucleic acid research via genetic code expansion, Nucleic Acids Res. 43(11), e73, https://doi.org/10.1093/nar/gkv202. · DOI
- Krauskopf, 2020, Increasing the chemical space of proteins in living cells via genetic code expansion, Curr. Opin. Chem. Biol., 58, 112, 10.1016/j.cbpa.2020.07.012 · DOI
- Drienovska, 2020, Expanding the enzyme universe with genetically encoded unnatural amino acids, Nat. Catal., 3, 193, 10.1038/s41929-019-0410-8 · DOI · Paper page
- Das, 2014, Identifying functionally important cis-peptide containing segments in proteins and their utility in molecular function annotation, FEBS J, 281, 5602, 10.1111/febs.13100 · DOI
- Lu, 2007, Prolyl cistransisomerization as a molecular timer, Nat. Chem. Biol., 3, 619, 10.1038/nchembio.2007.35 · DOI · Paper page
- Räder, 2018, Improving oral bioavailability of cyclic peptides by N-methylation, Bioorg. Med. Chem., 26, 2766, 10.1016/j.bmc.2017.08.031 · DOI · Paper page
- Teixeira, 2020, Nanomedicines for the delivery of antimicrobial peptides (AMPs), Nanomaterials, 10, 560, 10.3390/nano10030560 · DOI · Paper page
- Manniello, 2021, Insect antimicrobial peptides: potential weapons to counteract the antibiotic resistance, Cell. Mol. Life Sci., 78, 4259, 10.1007/s00018-021-03784-z · DOI · Paper page
- Lai, 2022, Strategies employed in the design of antimicrobial peptides with enhanced proteolytic stability, Biotechnol. Adv., 59, 107962, 10.1016/j.biotechadv.2022.107962 · DOI · Paper page
- Raj, 2021, Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy, Semin. Cancer Biol., 69, 166, 10.1016/j.semcancer.2019.11.002 · DOI · Paper page
- van Gent, 2021, Current advances in lipid and polymeric antimicrobial peptide delivery systems and coatings for the prevention and treatment of bacterial infections, Pharmaceutics, 13, 1840, 10.3390/pharmaceutics13111840 · DOI
- Thapa, 2020, Topical antimicrobial peptide formulations for wound healing: current developments and future prospects, Acta Biomater, 103, 52, 10.1016/j.actbio.2019.12.025 · DOI · Paper page
- Yao, 2018, Metabolism of peptide drugs and strategies to improve their metabolic stability, Curr. Drug Metabol., 19, 892, 10.2174/1389200219666180628171531 · doi:10.2174/1389200219666180628171531
- Wang, 2021, Antimicrobial peptides towards clinical application: delivery and formulation, Adv. Drug Deliv. Rev., 175, 113818, 10.1016/j.addr.2021.05.028 · DOI · Paper page
- Gan, 2021, The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions, Chem. Soc. Rev., 50, 7820, 10.1039/D0CS00729C · DOI · Paper page
- Gill, 2015, Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens, Chem. Biol. Drug Des., 85, 56, 10.1111/cbdd.12478 · DOI · Paper page
- Chen, 2022, Antimicrobial peptides: sustainable application informed by evolutionary constraints, Biotechnol. Adv., 60, 108012, 10.1016/j.biotechadv.2022.108012 · DOI
- Jiang, 2020, Targeting biofilms therapy: current research strategies and development hurdles, Microorganisms, 8, 1222, 10.3390/microorganisms8081222 · DOI · Paper page
- Dosler, 2013, In vitro pharmacokinetics of antimicrobial cationic peptides alone and in combination with antibiotics against methicillin resistant Staphylococcus aureus biofilms, Peptides, 49, 53, 10.1016/j.peptides.2013.08.008 · DOI
- Kumar, 2019, Aurein-derived antimicrobial peptides formulated with pegylated phospholipid micelles to target methicillin-resistant Staphylococcus aureus skin infections, ACS Infect. Dis., 5, 443, 10.1021/acsinfecdis.8b00319 · DOI
- Ma, 2017, Membrane-active amphipathic peptide WRL3 with in vitro antibiofilm capability and in vivo efficacy in treating methicillin-resistant Staphylococcus aureus burn wound infections, ACS Infect. Dis., 3, 820, 10.1021/acsinfecdis.7b00100 · DOI
- Menousek, 2012, Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300, Int. J. Antimicrob. Agents, 39, 402, 10.1016/j.ijantimicag.2012.02.003 · DOI
- M.F. Mohamed, A. Abdelkhalek, M. Seleem, Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus, Sci. Rep. 6 (1) (2016) 29707, https://doi.org/10.1038/srep29707. · DOI · Paper page
- Mohamed, 2014, Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides, Antimicrob. Agents Chemother., 58, 4113, 10.1128/AAC.02578-14 · DOI
- Mohamed, 1979, Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection, Drug Des. Dev. Ther.
- Kumar, 2018, Aurein-derived antimicrobial peptides formulated with pegylated phospholipid micelles to target methicillin-resistant Staphylococcus aureus skin infections, ACS Infect. Dis., 5, 443, 10.1021/acsinfecdis.8b00319 · DOI
- Sierra, 2017, An overview of antimicrobial peptides and the latest advances in their development, Expet Opin. Biol. Ther., 17, 663, 10.1080/14712598.2017.1315402 · DOI · Paper page
- Wang, 2022, Therapeutic peptides: current applications and future directions, Signal Transduct. Targeted Ther., 7, 48, 10.1038/s41392-022-00904-4 · DOI · Paper page
- Chow, 2019, Ligation technologies for the synthesis of cyclic peptides, Chem. Rev., 119, 9971, 10.1021/acs.chemrev.8b00657 · DOI · Paper page
- Barman, 2023, Strategic approaches to improvise peptide drugs as next generation therapeutics, Int. J. Pept. Res. Therapeut., 29, 61, 10.1007/s10989-023-10524-3 · DOI
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Metadata
- Authors
- Odunitan, T. T., Oyaronbi, A. O., Adebayo, F. A., Adekoyeni, P. A., Apanisile, B. T., Oladunni, T. D., & Saibu, O. A.
- ORCID
- Odunitan, Tope T.
- Venue
- Pharmaceutical Science Advances
- Publisher
- Elsevier BV
- Published
- 2024-12
- Volume
- 2
- Pages
- 100034
- ISSN
- 2773-2169
- Cited by
- 28
- References
- 11
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antimicrobial peptides: A novel and promising arsenal against methicillin-resistant Staphylococcus aureus (MRSA) infections. https://app.cochat.ai/papers/10.1016/j.pscia.2023.100034
- The paper
- Odunitan, T. T., Oyaronbi, A. O., Adebayo, F. A., Adekoyeni, P. A., Apanisile, B. T., Oladunni, T. D., & Saibu, O. A. (2024). Antimicrobial peptides: A novel and promising arsenal against methicillin-resistant Staphylococcus aureus (MRSA) infections. Pharmaceutical Science Advances. https://doi.org/10.1016/j.pscia.2023.100034
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.